These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26314534)

  • 21. Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan.
    Francischetti EA; Celoria BM; Francischetti A; Genelhu VA
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):289-303. PubMed ID: 18327991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of appropriate patients for cardiometabolic risk management.
    Peters AL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
    Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
    Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescent oligomenorrhea (age 14-19) tracks into the third decade of life (age 20-28) and predicts increased cardiovascular risk factors and metabolic syndrome.
    Glueck CJ; Woo JG; Khoury PR; Morrison JA; Daniels SR; Wang P
    Metabolism; 2015 Apr; 64(4):539-53. PubMed ID: 25633270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels.
    da Silva TF; Levy-Neto M; Bonfá E; Pereira RM
    J Rheumatol; 2013 Nov; 40(11):1897-904. PubMed ID: 24037555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome components and prevalence of cardiovascular disease among type 2 diabetic patients in Malaysia.
    Tan MC; Wong TW; Ng OC; Joseph A; Hejar AR
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):226-35. PubMed ID: 24964674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of metabolic syndrome components in adults with a healthy obese phenotype: a 3-year follow-up.
    den Engelsen C; Gorter KJ; Salomé PL; Rutten GE
    Obesity (Silver Spring); 2013 May; 21(5):1025-30. PubMed ID: 23404911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and renal disease.
    Gluba A; Mikhailidis DP; Lip GY; Hannam S; Rysz J; Banach M
    Int J Cardiol; 2013 Apr; 164(2):141-50. PubMed ID: 22305775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic syndrome.
    Garber AJ
    Med Clin North Am; 2004 Jul; 88(4):837-46, ix. PubMed ID: 15308381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Men's health in primary care: an emerging paradigm of sexual function and cardiometabolic risk.
    Miner MM
    Urol Clin North Am; 2012 Feb; 39(1):1-23. PubMed ID: 22118341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical consequences of obesity.
    Lawrence VJ; Kopelman PG
    Clin Dermatol; 2004; 22(4):296-302. PubMed ID: 15475229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome: what are the risks for humans?
    Gupta A; Gupta V
    Biosci Trends; 2010 Oct; 4(5):204-12. PubMed ID: 21068471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The concept of normal weight obesity.
    Oliveros E; Somers VK; Sochor O; Goel K; Lopez-Jimenez F
    Prog Cardiovasc Dis; 2014; 56(4):426-33. PubMed ID: 24438734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex dimorphism in the relation between early adiposity and cardiometabolic risk in adolescents.
    Huang RC; Mori TA; Burrows S; Le Ha C; Oddy WH; Herbison C; Hands BH; Beilin LJ
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E1014-22. PubMed ID: 22442267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MetS and cardiovascular risk factors among Palestinians of East Jerusalem.
    Abu Sham'a RA; Darwazah AK; Kufri FH; Yassin IH; Torok NI
    East Mediterr Health J; 2009; 15(6):1464-73. PubMed ID: 20218139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.